dc.date.accessioned | 2017-05-24T12:30:25Z | |
dc.date.available | 2017-05-24T12:30:25Z | |
dc.date.created | 2016-06-24T08:49:21Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Mihret, Wude Lema, Tsehaynesh Merid, Yared Kassu, Afework Abebe, Workeabeba Moges, Beyene Tenna, Admasu Woldegebriel, Fitsum Yidnekachew, Melaku Mekonnen, Wondale Yamuah, Lawrence Ahmed, Arslan Silamsaw, Mezgebu Petros, Beyene Oksnes, Jan Rosenqvist, Einar Ayele, Samuel Caugant, Dominique A Aseffa, Abraham Norheim, Gunnstein . Surveillance of bacterial meningitis, Ethiopia, 2012–2013. Emerging Infectious Diseases. 2016, 22(1), 75-78 | |
dc.identifier.uri | http://hdl.handle.net/10852/55491 | |
dc.description.abstract | Ethiopia has the second-largest population (≈94 million in 2013) among the meningitis belt countries of sub-Saharan Africa (1). However, during 2001–2010, a median of only 1,056 suspected meningitis cases per year (range 5–8,571/year) was reported to the World Health Organization (2). The largest meningitis epidemics occurred in 1981 (3) and 1989 (4), resulting in ≈45,000 and ≈50,000 cases, respectively. Serogroup A meningococci were the major cause of these epidemics, although serogroup C strains were also identified in 1981, 1983–84, and during outbreaks in 2000 and 2003 (5). Conjugate vaccines against Haemophilus influenzae serotype b, Streptococcus pneumoniae (pneumococcal conjugate vaccine [PCV] 10), and Neisseria meningitidis serogroup A (MenAfriVac) were introduced in 2007, 2011, and 2013–2015, respectively. Because data permitting assessment of these vaccines are limited, we implemented a surveillance study. | en_US |
dc.language | EN | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.title | Surveillance of bacterial meningitis, Ethiopia, 2012–2013 | en_US |
dc.type | Journal article | en_US |
dc.creator.author | Mihret, Wude | |
dc.creator.author | Lema, Tsehaynesh | |
dc.creator.author | Merid, Yared | |
dc.creator.author | Kassu, Afework | |
dc.creator.author | Abebe, Workeabeba | |
dc.creator.author | Moges, Beyene | |
dc.creator.author | Tenna, Admasu | |
dc.creator.author | Woldegebriel, Fitsum | |
dc.creator.author | Yidnekachew, Melaku | |
dc.creator.author | Mekonnen, Wondale | |
dc.creator.author | Yamuah, Lawrence | |
dc.creator.author | Ahmed, Arslan | |
dc.creator.author | Silamsaw, Mezgebu | |
dc.creator.author | Petros, Beyene | |
dc.creator.author | Oksnes, Jan | |
dc.creator.author | Rosenqvist, Einar | |
dc.creator.author | Ayele, Samuel | |
dc.creator.author | Caugant, Dominique A | |
dc.creator.author | Aseffa, Abraham | |
dc.creator.author | Norheim, Gunnstein | |
cristin.unitcode | 185,52,14,0 | |
cristin.unitname | Avdeling for samfunnsmedisin og global helse | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |
dc.identifier.cristin | 1363886 | |
dc.identifier.bibliographiccitation | info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Emerging Infectious Diseases&rft.volume=22&rft.spage=75&rft.date=2016 | |
dc.identifier.jtitle | Emerging Infectious Diseases | |
dc.identifier.volume | 22 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 75 | |
dc.identifier.endpage | 78 | |
dc.identifier.doi | http://dx.doi.org/10.3201/eid2201.150432 | |
dc.identifier.urn | URN:NBN:no-58277 | |
dc.type.document | Tidsskriftartikkel | en_US |
dc.type.peerreviewed | Peer reviewed | |
dc.source.issn | 1080-6040 | |
dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/55491/1/Mihret_2016_Sur.pdf | |
dc.type.version | PublishedVersion | |